SCHEMBL17134331

SCHEMBL17134331

CC(=O)N(C)c1cccc(/C(C)=N/O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.39
GFER P55789 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
BRD4 O60885 1/20 0.39
LIN28A Q9H9Z2 1/20 0.39
HSD17B2 P37059 2/20 0.38
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HSD17B1 P14061 1/20 0.37
PDK2 Q15119 1/20 0.37
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17134332 1.00 CASP3 (0.39) CASP3GFERSENP8SENP7SENP6
SCHEMBL2894413 0.82 HTT (0.46) BRD4LIN28AHSD17B2MAPTKDM4E
SCHEMBL15761122 0.82 ALDH1A1 (0.48) CASP3GFERSENP8SENP7SENP6
SCHEMBL9229295 0.81 CA12 (0.47) MAPTKDM4EGAAKMT2AL3MBTL1
SCHEMBL3106119 0.79 PARP1 (0.52) BRD4LIN28AMAPTL3MBTL1POLB
SCHEMBL8020919 0.79 MAPT (0.38) HSD17B2MAPTKDM4EGAAKMT2A
SCHEMBL8022508 0.77 MAPT (0.37) HSD17B2MAPTKDM4EGAAKMT2A
SCHEMBL8020917 0.77 MAPT (0.37) HSD17B2MAPTKDM4EGAAKMT2A
SCHEMBL6689403 0.77 ALDH1A1 (0.46) BRD4LIN28AHSD17B2MAPTKDM4E
SCHEMBL11409410 0.74 ALDH1A1 (0.52) GFERBRD4LIN28AHSD17B2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2927218-B1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2018-07-04 EP disclosed
US-9725423-B2 Tetrazolinone compound and applications thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-08-08 US disclosed
US-20150299146-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-22 US disclosed
EP-2927218-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299146-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF RTN3, CYCS, ATL3 CASP3 10/4885GFER 2649/4885SENP8 3571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.